Andrew Hykes - 10 Feb 2025 Form 4 Insider Report for Inari Medical, Inc.

Reporting relationship: President and CEO, Director
Issuer ticker: N/A
Reported as of: 10 Feb 2025
Net transaction value: +$184,569
SEC form: 4
Accepted by SEC: 12 Feb 2025, 16:42:56 UTC
Prior SEC filing: 06 Feb 2025
Next SEC filing: 19 Feb 2025
Source filing: View source filing
Reporting owner signature: /s/ Shannon Trevino, attorney-in-fact for Andrew Hykes

Key filing fact

Andrew Hykes filed Form 4 for Inari Medical, Inc. on 12 Feb 2025.

Key facts

This page summarizes Andrew Hykes's Form 4 filing for Inari Medical, Inc..
6 reported transactions and 3 derivative rows are listed below.
Accepted by SEC: 12 Feb 2025, 16:42.

Change

Previous filing in this sequence was filed on 06 Feb 2025.
Current net transaction value: +$184,569.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NARI transaction

Common Stock

Options Exercise

Transaction value: $69,015
Shares: +161,100
Change %: +32%
Price: $0.4284
Shares after: 663,806
Date: 10 Feb 2025
Ownership: Direct

NARI transaction

Common Stock

Options Exercise

Transaction value: $107,914
Shares: +16,719
Change %: +2.5%
Price: $6.45
Shares after: 680,525
Date: 10 Feb 2025
Ownership: Direct

NARI transaction

Common Stock

Options Exercise

Transaction value: $7,639
Shares: +16,719
Change %: +2.5%
Price: $0.4569
Shares after: 697,244
Date: 10 Feb 2025
Ownership: Direct

NARI holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 1,550
Date: 10 Feb 2025
Ownership: By Child 1

NARI holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 1,550
Date: 10 Feb 2025
Ownership: By Child 2

NARI holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 1,550
Date: 10 Feb 2025
Ownership: By Child 3

NARI holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 1,000
Date: 10 Feb 2025
Ownership: By Spouse

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NARI transaction Derivative

Stock Options (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -161,100
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 10 Feb 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 161,100
Exercise price: $0.4284
Footnotes: F1

NARI transaction Derivative

Stock Option

Options Exercise

Transaction value: $0
Shares: -16,719
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 10 Feb 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 16,719
Exercise price: $6.45
Footnotes: F2

NARI transaction Derivative

Stock Option

Options Exercise

Transaction value: $0
Shares: -16,719
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 10 Feb 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 16,719
Exercise price: $0.4569
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The option became fully vested and exercisable as of March 29, 2022.

Footnote F2

The option became fully vested and exercisable as of January 1, 2024.

Footnote F3

The option became fully vested and exercisable as of January 1, 2023.